List of molecules and drugs that target protein P11229

#	DrugDomain Data	DrugBank Accession	Name	Drug action	Affinity data	InChI Key	SMILES
1	P11229_DB00185	DB00185	Cevimeline	agonist		WUTYZMFRCNBCHQ-LHIURRSHSA-N	CC1O[C@@]2(CS1)CN1CCC2CC1
2	P11229_DB00193	DB00193	Tramadol	antagonist		TVYLLZQTGLZFBW-UHFFFAOYSA-N	COC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C
3	P11229_DB00209	DB00209	Trospium	antagonist		OYYDSUSKLWTMMQ-JKHIJQBDSA-N	[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)[N+]21CCCC1
4	P11229_DB00219	DB00219	Oxyphenonium	antagonist		GFRUPHOKLBPHTQ-UHFFFAOYSA-N	CC[N+](C)(CC)CCOC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1
5	P11229_DB00245	DB00245	Benzatropine	antagonist		GIJXKZJWITVLHI-PMOLBWCYSA-N	[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C
6	P11229_DB00246	DB00246	Ziprasidone	antagonist	Ki(nM) = 300.0	MVWVFYHBGMAFLY-UHFFFAOYSA-N	ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1
7	P11229_DB00280	DB00280	Disopyramide	antagonist		UVTNFZQICZKOEM-UHFFFAOYSA-N	CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C
8	P11229_DB00332	DB00332	Ipratropium	antagonist		OEXHQOGQTVQTAT-BHIXFJMTSA-N	[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(CO)C1=CC=CC=C1)[N+]2(C)C(C)C
9	P11229_DB00334	DB00334	Olanzapine	antagonist	Ki(nM) = 2.1 EC50(nM) = 100000.0	KVWDHTXUZHCGIO-UHFFFAOYSA-N	CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
10	P11229_DB00342	DB00342	Terfenadine	binder	IC50(nM) = 2900.0	GUGOEEXESWIERI-UHFFFAOYSA-N	CC(C)(C)C1=CC=C(C=C1)C(O)CCCN1CCC(CC1)C(O)(C1=CC=CC=C1)C1=CC=CC=C1
11	P11229_DB00354	DB00354	Buclizine	antagonist		MOYGZHXDRJNJEP-UHFFFAOYSA-N	CC(C)(C)C1=CC=C(CN2CCN(CC2)C(C2=CC=CC=C2)C2=CC=C(Cl)C=C2)C=C1
12	P11229_DB00363	DB00363	Clozapine	antagonist	Ki(nM) = 0.98 IC50(nM) = 9.4 EC50(nM) = 10000.0	QZUDBNBUXVUHMW-UHFFFAOYSA-N	CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=CC=CC=C12
13	P11229_DB00376	DB00376	Trihexyphenidyl	antagonist	Ki(nM) = 0.37 IC50(nM) = 1.3	HWHLPVGTWGOCJO-UHFFFAOYSA-N	OC(CCN1CCCCC1)(C1CCCCC1)C1=CC=CC=C1
14	P11229_DB00383	DB00383	Oxyphencyclimine	antagonist		DUDKAZCAISNGQN-UHFFFAOYSA-N	CN1CCCN=C1COC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1
15	P11229_DB00387	DB00387	Procyclidine	antagonist	Ki(nM) = 4.6	WYDUSKDSKCASEF-UHFFFAOYSA-N	OC(CCN1CCCC1)(C1CCCCC1)C1=CC=CC=C1
16	P11229_DB00392	DB00392	Profenamine	antagonist		CDOZDBSBBXSXLB-UHFFFAOYSA-N	CCN(CC)C(C)CN1C2=CC=CC=C2SC2=CC=CC=C12
17	P11229_DB00408	DB00408	Loxapine	binder	Ki(nM) = 63.9 IC50(nM) = 5500.0	XJGVXQDUIWGIRW-UHFFFAOYSA-N	CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2
18	P11229_DB00411	DB00411	Carbamoylcholine	agonist	Ki(nM) = 29.0 IC50(nM) = 457.0 EC50(nM) = 250.0	VPJXQGSRWJZDOB-UHFFFAOYSA-O	C[N+](C)(C)CCOC(N)=O
19	P11229_DB00420	DB00420	Promazine	antagonist		ZGUGWUXLJSTTMA-UHFFFAOYSA-N	CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C12
20	P11229_DB00424	DB00424	Hyoscyamine	antagonist		RKUNBYITZUJHSG-FXUDXRNXSA-N	CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1
21	P11229_DB00434	DB00434	Cyproheptadine	antagonist	Ki(nM) = 12.0	JJCFRYNCJDLXIK-UHFFFAOYSA-N	CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=CC=CC=C12
22	P11229_DB00458	DB00458	Imipramine	antagonist	Ki(nM) = 42.0	BCGWQEUPMDMJNV-UHFFFAOYSA-N	CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12
23	P11229_DB00462	DB00462	Methscopolamine bromide	antagonist		CXYRUNPLKGGUJF-RAFJPFSSSA-M	[Br-].[H][C@@]12O[C@]1([H])[C@H]1C[C@H](C[C@@H]2[N+]1(C)C)OC(=O)[C@H](CO)C1=CC=CC=C1
24	P11229_DB00477	DB00477	Chlorpromazine	antagonist	Ki(nM) = 25.0	ZPEIMTDSQAKGNT-UHFFFAOYSA-N	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2
25	P11229_DB00483	DB00483	Gallamine triethiodide	n/a	Ki(nM) = 8511.38 EC50(nM) = 170000.0	REEUVFCVXKWOFE-UHFFFAOYSA-K	[I-].[I-].[I-].CC[N+](CC)(CC)CCOC1=CC=CC(OCC[N+](CC)(CC)CC)=C1OCC[N+](CC)(CC)CC
26	P11229_DB00496	DB00496	Darifenacin	antagonist	Ki(nM) = 5.5	HXGBXQDTNZMWGS-RUZDIDTESA-N	NC(=O)C([C@@H]1CCN(CCC2=CC3=C(OCC3)C=C2)C1)(C1=CC=CC=C1)C1=CC=CC=C1
27	P11229_DB00505	DB00505	Tridihexethyl	antagonist		NPRHVSBSZMAEIN-UHFFFAOYSA-N	CC[N+](CC)(CC)CCC(O)(C1CCCCC1)C1=CC=CC=C1
28	P11229_DB00508	DB00508	Triflupromazine	antagonist		XSCGXQMFQXDFCW-UHFFFAOYSA-N	CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F
29	P11229_DB00517	DB00517	Anisotropine methylbromide	antagonist		QSFKGMJOKUZAJM-UHFFFAOYSA-M	[Br-].CCCC(CCC)C(=O)O[C@H]1CC2CCC(C1)[N+]2(C)C
30	P11229_DB00543	DB00543	Amoxapine	antagonist		QWGDMFLQWFTERH-UHFFFAOYSA-N	ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1
31	P11229_DB00572	DB00572	Atropine	antagonist	Ki(nM) = 0.3	RKUNBYITZUJHSG-SPUOUPEWSA-N	CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1
32	P11229_DB00622	DB00622	Nicardipine	antagonist		ZBBHBTPTTSWHBA-UHFFFAOYSA-N	COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1
33	P11229_DB00670	DB00670	Pirenzepine	antagonist	Ki(nM) = 2.82 IC50(nM) = 1.5 Kd(nM) = 20.0	RMHMFHUVIITRHF-UHFFFAOYSA-N	CN1CCN(CC(=O)N2C3=CC=CC=C3C(=O)NC3=C2N=CC=C3)CC1
34	P11229_DB00725	DB00725	Homatropine methylbromide	antagonist		FUFVKLQESJNNAN-UHFFFAOYSA-M	[Br-].C[N+]1(C)C2CCC1CC(C2)OC(=O)C(O)C1=CC=CC=C1
35	P11229_DB00747	DB00747	Scopolamine	antagonist		STECJAGHUSJQJN-FWXGHANASA-N	CN1[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1
36	P11229_DB00767	DB00767	Benzquinamide	antagonist		JSZILQVIPPROJI-UHFFFAOYSA-N	CCN(CC)C(=O)C1CN2CCC3=CC(OC)=C(OC)C=C3C2CC1OC(C)=O
37	P11229_DB00771	DB00771	Clidinium	antagonist		HOOSGZJRQIVJSZ-NNBUQUNQSA-N	C[N@@+]12CC[C@@H](CC1)C(C2)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1
38	P11229_DB00782	DB00782	Propantheline	antagonist		VVWYOYDLCMFIEM-UHFFFAOYSA-N	CC(C)[N+](C)(CCOC(=O)C1C2=CC=CC=C2OC2=CC=CC=C12)C(C)C
39	P11229_DB00804	DB00804	Dicyclomine	antagonist		CURUTKGFNZGFSE-UHFFFAOYSA-N	CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1
40	P11229_DB00805	DB00805	Minaprine	agonist	Ki(nM) = 17000.0	LDMWSLGGVTVJPG-UHFFFAOYSA-N	CC1=CC(=NN=C1NCCN1CCOCC1)C1=CC=CC=C1
41	P11229_DB00809	DB00809	Tropicamide	antagonist		BGDKAVGWHJFAGW-UHFFFAOYSA-N	CCN(CC1=CC=NC=C1)C(=O)C(CO)C1=CC=CC=C1
42	P11229_DB00810	DB00810	Biperiden	antagonist	Ki(nM) = 0.48	YSXKPIUOCJLQIE-UHFFFAOYSA-N	OC(CCN1CCCCC1)(C1CC2CC1C=C2)C1=CC=CC=C1
43	P11229_DB00835	DB00835	Brompheniramine	antagonist		ZDIGNSYAACHWNL-UHFFFAOYSA-N	CN(C)CCC(C1=CC=C(Br)C=C1)C1=CC=CC=N1
44	P11229_DB00875	DB00875	Flupentixol	antagonist		NJMYODHXAKYRHW-DVZOWYKESA-N	[H]\C(CCN1CCN(CCO)CC1)=C1/C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F
45	P11229_DB00907	DB00907	Cocaine	antagonist		ZPUCINDJVBIVPJ-LJISPDSOSA-N	[H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C
46	P11229_DB00934	DB00934	Maprotiline	antagonist		QSLMDECMDJKHMQ-UHFFFAOYSA-N	CNCCCC12CCC(C3=CC=CC=C13)C1=CC=CC=C21
47	P11229_DB00940	DB00940	Methantheline	antagonist		GZHFODJQISUKAY-UHFFFAOYSA-N	CC[N+](C)(CC)CCOC(=O)C1C2=CC=CC=C2OC2=CC=CC=C12
48	P11229_DB00942	DB00942	Cycrimine	antagonist		SWRUZBWLEWHWRI-UHFFFAOYSA-N	OC(CCN1CCCCC1)(C1CCCC1)C1=CC=CC=C1
49	P11229_DB00979	DB00979	Cyclopentolate	antagonist		SKYSRIRYMSLOIN-UHFFFAOYSA-N	CN(C)CCOC(=O)C(C1=CC=CC=C1)C1(O)CCCC1
50	P11229_DB00986	DB00986	Glycopyrronium	antagonist	IC50(nM) = 0.126	ANGKOCUUWGHLCE-UHFFFAOYSA-N	C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)C1=CC=CC=C1
51	P11229_DB01019	DB01019	Bethanechol	agonist	Ki(nM) = 190.0	NZUPCNDJBJXXRF-UHFFFAOYSA-O	CC(C[N+](C)(C)C)OC(N)=O
52	P11229_DB01036	DB01036	Tolterodine	antagonist	Ki(nM) = 1.4	OOGJQPCLVADCPB-HXUWFJFHSA-N	CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(O)C=CC(C)=C1)C(C)C
53	P11229_DB01062	DB01062	Oxybutynin	antagonist	Ki(nM) = 1.0	XIQVNETUBQGFHX-UHFFFAOYSA-N	CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1
54	P11229_DB01069	DB01069	Promethazine	antagonist		PWWVAXIEGOYWEE-UHFFFAOYSA-N	CC(CN1C2=CC=CC=C2SC2=CC=CC=C12)N(C)C
55	P11229_DB01085	DB01085	Pilocarpine	agonist	Ki(nM) = 12.0 Kd(nM) = 2692.0 EC50(nM) = 18.0	QCHFTSOMWOSFHM-WPRPVWTQSA-N	CC[C@H]1[C@@H](CC2=CN=CN2C)COC1=O
56	P11229_DB01142	DB01142	Doxepin	antagonist		ODQWQRRAPPTVAG-UHFFFAOYSA-N	[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12
57	P11229_DB01148	DB01148	Flavoxate	antagonist		SPIUTQOUKAMGCX-UHFFFAOYSA-N	CC1=C(OC2=C(C=CC=C2C(=O)OCCN2CCCCC2)C1=O)C1=CC=CC=C1
58	P11229_DB01151	DB01151	Desipramine	antagonist	Ki(nM) = 110.0	HCYAFALTSJYZDH-UHFFFAOYSA-N	CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12
59	P11229_DB01175	DB01175	Escitalopram	inhibitor		WSEQXVZVJXJVFP-FQEVSTJZSA-N	CN(C)CCC[C@]1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1
60	P11229_DB01224	DB01224	Quetiapine	antagonist	Ki(nM) = 56.0 EC50(nM) = 10000.0	URKOMYMAXPYINW-UHFFFAOYSA-N	OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
61	P11229_DB01231	DB01231	Diphenidol	antagonist		OGAKLTJNUQRZJU-UHFFFAOYSA-N	OC(CCCN1CCCCC1)(C1=CC=CC=C1)C1=CC=CC=C1
62	P11229_DB01233	DB01233	Metoclopramide	agonist		TTWJBBZEZQICBI-UHFFFAOYSA-N	CCN(CC)CCNC(=O)C1=CC(Cl)=C(N)C=C1OC
63	P11229_DB01238	DB01238	Aripiprazole	ligand	Ki(nM) = 6780.0	CEUORZQYGODEFX-UHFFFAOYSA-N	ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl
64	P11229_DB01239	DB01239	Chlorprothixene	antagonist		WSPOMRSOLSGNFJ-AUWJEWJLSA-N	CN(C)CC\C=C1\C2=CC=CC=C2SC2=CC=C(Cl)C=C12
65	P11229_DB01403	DB01403	Methotrimeprazine	antagonist		VRQVVMDWGGWHTJ-CQSZACIVSA-N	COC1=CC2=C(SC3=C(C=CC=C3)N2C[C@H](C)CN(C)C)C=C1
66	P11229_DB01409	DB01409	Tiotropium	antagonist		LERNTVKEWCAPOY-DZZGSBJMSA-N	[H][C@]12O[C@@]1([H])[C@]1([H])C[C@@]([H])(C[C@@]2([H])[N+]1(C)C)OC(=O)C(O)(C1=CC=CS1)C1=CC=CS1
67	P11229_DB01591	DB01591	Solifenacin	antagonist	Ki(nM) = 51.0 IC50(nM) = 63.5	FBOUYBDGKBSUES-VXKWHMMOSA-N	O=C(O[C@H]1CN2CCC1CC2)N1CCC2=CC=CC=C2[C@@H]1C1=CC=CC=C1
68	P11229_DB01618	DB01618	Molindone	other/unknown		KLPWJLBORRMFGK-UHFFFAOYSA-N	CCC1=C(C)NC2=C1C(=O)C(CN1CCOCC1)CC2
69	P11229_DB02010	DB02010	Staurosporine	n/a		HKSZLNNOFSGOKW-FYTWVXJKSA-N	[H][C@]1(C[C@@]2([H])O[C@](C)(N3C4=CC=CC=C4C4=C5CNC(=O)C5=C5C6=CC=CC=C6N2C5=C34)[C@]1([H])OC)NC
70	P11229_DB03128	DB03128	Acetylcholine	n/a	Ki(nM) = 3.4 IC50(nM) = 135.0 Kd(nM) = 17378.0 EC50(nM) = 1.1	OIPILFWXSMYKGL-UHFFFAOYSA-N	CC(=O)OCC[N+](C)(C)C
71	P11229_DB04365	DB04365	Arecoline	n/a	Ki(nM) = 4.1 IC50(nM) = 115.0 EC50(nM) = 3200.0	HJJPJSXJAXAIPN-UHFFFAOYSA-N	COC(=O)C1=CCCN(C)C1
72	P11229_DB04843	DB04843	Mepenzolate	antagonist		GKNPSSNBBWDAGH-UHFFFAOYSA-N	C[N+]1(C)CCCC(C1)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1
73	P11229_DB05152	DB05152	NGX267	n/a		PHOZOHFUXHPOCK-QMMMGPOBSA-N	CC[C@@H]1SC2(CCN(C)CC2)NC1=O
74	P11229_DB05766	DB05766	Norclozapine	n/a		JNNOSTQEZICQQP-UHFFFAOYSA-N	ClC1=CC=C2NC3=C(C=CC=C3)C(=NC2=C1)N1CCNCC1
75	P11229_DB06153	DB06153	Pizotifen	antagonist		FIADGNVRKBPQEU-UHFFFAOYSA-N	CN1CCC(CC1)=C1C2=C(CCC3=CC=CC=C13)SC=C2
76	P11229_DB06702	DB06702	Fesoterodine	antagonist		DCCSDBARQIPTGU-HSZRJFAPSA-N	CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(OC(=O)C(C)C)C=CC(CO)=C1)C(C)C
77	P11229_DB06709	DB06709	Methacholine	agonist	Ki(nM) = 23.0	NZWOPGCLSHLLPA-UHFFFAOYSA-N	CC(C[N+](C)(C)C)OC(C)=O
78	P11229_DB06787	DB06787	Hexocyclium	antagonist		ZRYHPQCHHOKSMD-UHFFFAOYSA-N	C[N+]1(C)CCN(CC(O)(C2CCCCC2)C2=CC=CC=C2)CC1
79	P11229_DB08897	DB08897	Aclidinium	antagonist	Ki(nM) = 0.08 IC50(nM) = 0.1	ASMXXROZKSBQIH-VITNCHFBSA-N	OC(C(=O)O[C@H]1C[N+]2(CCCOC3=CC=CC=C3)CCC1CC2)(C1=CC=CS1)C1=CC=CS1
80	P11229_DB09076	DB09076	Umeclidinium	antagonist	Ki(nM) = 0.16	FVTWTVQXNAJTQP-UHFFFAOYSA-N	OC(C1=CC=CC=C1)(C1=CC=CC=C1)C12CC[N+](CCOCC3=CC=CC=C3)(CC1)CC2
81	P11229_DB09089	DB09089	Trimebutine	antagonist		LORDFXWUHHSAQU-UHFFFAOYSA-N	CCC(COC(=O)C1=CC(OC)=C(OC)C(OC)=C1)(N(C)C)C1=CC=CC=C1
82	P11229_DB09167	DB09167	Dosulepin	antagonist		PHTUQLWOUWZIMZ-GZTJUZNOSA-N	CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12
83	P11229_DB09185	DB09185	Viloxazine	antagonist		YWPHCCPCQOJSGZ-UHFFFAOYSA-N	CCOC1=CC=CC=C1OCC1CNCCO1
84	P11229_DB09262	DB09262	Imidafenacin	antagonist		SQKXYSGRELMAAU-UHFFFAOYSA-N	CC1=NC=CN1CCC(C(N)=O)(C1=CC=CC=C1)C1=CC=CC=C1
85	P11229_DB11156	DB11156	Pyrantel	antagonist		YSAUAVHXTIETRK-AATRIKPKSA-N	[H]\C(=C(\[H])C1=NCCCN1C)C1=CC=CS1
86	P11229_DB11181	DB11181	Homatropine	antagonist		ZTVIKZXZYLEVOL-MCOXGKPRSA-N	[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(O)C1=CC=CC=C1)N2C
87	P11229_DB11235	DB11235	Thonzylamine	antagonist		GULNIHOSWFYMRN-UHFFFAOYSA-N	COC1=CC=C(CN(CCN(C)C)C2=NC=CC=N2)C=C1
88	P11229_DB12278	DB12278	Propiverine	antagonist		QPCVHQBVMYCJOM-UHFFFAOYSA-N	CCCOC(C(=O)OC1CCN(C)CC1)(C1=CC=CC=C1)C1=CC=CC=C1
89	P11229_DB13581	DB13581	Rociverine	antagonist		XPYLKZZOBVLVHB-QDKIRNHSSA-N	CCN(CC)CC(C)OC(=O)[C@H]1CCCC[C@]1(O)C1CCCCC1
90	P11229_DB14185	DB14185	Aripiprazole lauroxil	n/a		DDINXHAORAAYAD-UHFFFAOYSA-N	CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12